• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

牙髓和根尖周疾病作为颌骨坏死的危险因素:韩国一项基于全国队列的研究。

Pulp and periapical disease as a risk factor for osteonecrosis of the jaw: a national cohort-based study in Korea.

作者信息

Baek Hyeong-Jin, Lee Hyejin, Lee Jae-Ryun, Park Jung-Hyun, Kim Keun-Suh, Kwoen Min-Jeong, Lee Tae-Yeon, Kim Jin-Woo, Lee Hyo-Jung

机构信息

Department of Periodontology, Section of Dentistry, Seoul National University Bundang Hospital, Seongnam, Korea.

Department of Family Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.

出版信息

J Periodontal Implant Sci. 2024 Apr;54(2):65-74. doi: 10.5051/jpis.2300120006. Epub 2023 Jun 16.

DOI:10.5051/jpis.2300120006
PMID:37524381
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11065535/
Abstract

PURPOSE

This longitudinal cohort study aimed to evaluate the relationship between osteonecrosis of the jaw and pulp and periapical disease in patients who were administered bisphosphonates.

METHODS

Using data from a nationwide cohort, we examined the association among dental caries, pulp and periapical disease, and osteonecrosis of the jaw in women aged >50 years who received bisphosphonates for more than 1 year between 2002 and 2015. Because of ambiguities in the diagnosis of osteonecrosis of the jaw in population-based data, we operationally defined and categorized the condition into established and potential osteonecrosis of the jaw.

RESULTS

Pulp and periapical disease significantly increased the development of both established and potential osteonecrosis of the jaw (hazard ratio, 2.21; 95% confidence interval, 1.40-3.48; and hazard ratio, 2.22; 95% confidence interval, 1.65-2.98, respectively). Root canal treatment did not have any influence on the development of osteonecrosis of the jaw.

CONCLUSIONS

Pulp and periapical disease may be a major risk factor for osteonecrosis of the jaw. The study findings suggest that patients should undergo regular dental examinations to detect pulp and periapical disease before or during the administration of bisphosphonates and that root canal treatment should be considered to decrease the risk of osteonecrosis of the jaw.

摘要

目的

这项纵向队列研究旨在评估接受双膦酸盐治疗的患者颌骨坏死与牙髓及根尖周疾病之间的关系。

方法

利用全国性队列的数据,我们研究了2002年至2015年期间年龄大于50岁且接受双膦酸盐治疗超过1年的女性中龋齿、牙髓及根尖周疾病与颌骨坏死之间的关联。由于基于人群的数据中颌骨坏死诊断存在模糊性,我们在操作上对该病症进行定义并分类为确诊颌骨坏死和疑似颌骨坏死。

结果

牙髓及根尖周疾病显著增加了确诊颌骨坏死和疑似颌骨坏死的发生风险(风险比分别为2.21;95%置信区间为1.40 - 3.48;以及风险比为2.22;95%置信区间为1.65 - 2.98)。根管治疗对颌骨坏死的发生没有任何影响。

结论

牙髓及根尖周疾病可能是颌骨坏死的主要危险因素。研究结果表明,患者在接受双膦酸盐治疗之前或期间应定期进行牙科检查以检测牙髓及根尖周疾病,并且应考虑进行根管治疗以降低颌骨坏死的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0bc/11065535/21ea936a3111/jpis-54-65-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0bc/11065535/21ea936a3111/jpis-54-65-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0bc/11065535/21ea936a3111/jpis-54-65-g001.jpg

相似文献

1
Pulp and periapical disease as a risk factor for osteonecrosis of the jaw: a national cohort-based study in Korea.牙髓和根尖周疾病作为颌骨坏死的危险因素:韩国一项基于全国队列的研究。
J Periodontal Implant Sci. 2024 Apr;54(2):65-74. doi: 10.5051/jpis.2300120006. Epub 2023 Jun 16.
2
Preexisting Periapical Inflammatory Condition Exacerbates Tooth Extraction-induced Bisphosphonate-related Osteonecrosis of the Jaw Lesions in Mice.既往根尖周炎症状态会加重拔牙诱导的小鼠双膦酸盐相关颌骨坏死病变。
J Endod. 2016 Nov;42(11):1641-1646. doi: 10.1016/j.joen.2016.07.020. Epub 2016 Sep 13.
3
Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.口服双膦酸盐类药物患者植入牙种植体的疗效:115例病例回顾
J Oral Maxillofac Surg. 2008 Feb;66(2):223-30. doi: 10.1016/j.joms.2007.09.019.
4
Avascular mandibular osteonecrosis in association with bisphosphonate therapy: a report on four patients.双膦酸盐治疗相关的无血管性下颌骨坏死:4例病例报告
Anticancer Res. 2007 Jul-Aug;27(4A):1841-5.
5
Clinical impact of bisphosphonates in root canal therapy.双膦酸盐在根管治疗中的临床影响。
Saudi Med J. 2018 Mar;39(3):232-238. doi: 10.15537/smj.2018.3.20923.
6
Pulpal Disease Arising from Medication-related Osteonecrosis of the Jaw: A Case Report.药物相关性颌骨骨坏死导致的牙髓病:病例报告。
J Endod. 2020 Aug;46(8):1149-1154. doi: 10.1016/j.joen.2020.04.010. Epub 2020 May 8.
7
Osteonecrosis of the jaw in older osteoporosis patients treated with intravenous bisphosphonates.静脉用双膦酸盐治疗的老年骨质疏松症患者的颌骨坏死。
Ann Pharmacother. 2011 Oct;45(10):1199-206. doi: 10.1345/aph.1Q239. Epub 2011 Sep 27.
8
Periapical bacterial disinfection is critical for dental pulp regenerative cell therapy in apical periodontitis in dogs.根尖周病的牙髓再生细胞治疗中,根尖周细菌消毒对犬至关重要。
Stem Cell Res Ther. 2024 Jan 17;15(1):17. doi: 10.1186/s13287-023-03628-6.
9
Use of oral bisphosphonates and risk of hospital admission with osteonecrosis of the jaw: Large prospective cohort study in UK women.口服双膦酸盐的使用与颌骨坏死住院风险的相关性:英国女性的大型前瞻性队列研究。
Bone. 2019 Jul;124:69-74. doi: 10.1016/j.bone.2019.04.003. Epub 2019 Apr 5.
10
Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw With Plasma Rich in Growth Factors After Dental Implant Surgery: A Case Report.种植牙手术后应用富含生长因子的血浆治疗双膦酸盐相关颌骨坏死:一例报告
J Oral Implantol. 2019 Aug;45(4):289-296. doi: 10.1563/aaid-joi-D-18-00254. Epub 2019 Jun 17.

引用本文的文献

1
Clinical Performance of Implant-Supported Prostheses in the Rehabilitation of Patients Previously Treated for Medication-Related Osteonecrosis of the Jaws (MRONJ): A Systematic Review.种植体支持式修复体用于曾接受药物相关性颌骨坏死(MRONJ)治疗患者康复的临床性能:一项系统评价
Cureus. 2024 Jun 4;16(6):e61658. doi: 10.7759/cureus.61658. eCollection 2024 Jun.

本文引用的文献

1
Pathogenesis and multidisciplinary management of medication-related osteonecrosis of the jaw.药物相关性颌骨骨坏死的发病机制与多学科管理。
Int J Oral Sci. 2020 Oct 21;12(1):30. doi: 10.1038/s41368-020-00093-2.
2
Medication-Related Osteonecrosis of the Jaws.药物相关性颌骨坏死
J Natl Cancer Inst Monogr. 2019 Aug 1;2019(53). doi: 10.1093/jncimonographs/lgz009.
3
The influence of alendronate and tooth extraction on the incidence of osteonecrosis of the jaw among osteoporotic subjects.阿仑膦酸盐和拔牙对骨质疏松患者颌骨坏死发生率的影响。
PLoS One. 2018 Apr 25;13(4):e0196419. doi: 10.1371/journal.pone.0196419. eCollection 2018.
4
Cohort profile: the National Health Insurance Service-National Health Screening Cohort (NHIS-HEALS) in Korea.队列简介:韩国国家健康保险服务-国家健康筛查队列(NHIS-HEALS)。
BMJ Open. 2017 Sep 24;7(9):e016640. doi: 10.1136/bmjopen-2017-016640.
5
Medication-related osteonecrosis of the jaws (MRONJ) and quality of life evaluation: a pilot study.药物相关性颌骨坏死(MRONJ)与生活质量评估:一项初步研究。
Clin Ter. 2017 Jul-Aug;168(4):e253-e257. doi: 10.7417/T.2017.2015.
6
Risk factors of osteonecrosis of the jaw after tooth extraction in osteoporotic patients on oral bisphosphonates.口服双膦酸盐的骨质疏松症患者拔牙后颌骨坏死的危险因素。
Imaging Sci Dent. 2017 Mar;47(1):45-50. doi: 10.5624/isd.2017.47.1.45. Epub 2017 Mar 21.
7
Skeletal Site-specific Effects of Zoledronate on in vivo Bone Remodeling and in vitro BMSCs Osteogenic Activity.唑来膦酸对体内骨重建和体外 BMSCs 成骨活性的骨骼部位特异性影响。
Sci Rep. 2017 Jan 31;7:36129. doi: 10.1038/srep36129.
8
Case-Based Review of Osteonecrosis of the Jaw (ONJ) and Application of the International Recommendations for Management From the International Task Force on ONJ.基于病例的颌骨骨坏死(ONJ)回顾及国际ONJ特别工作组国际管理建议的应用
J Clin Densitom. 2017 Jan-Mar;20(1):8-24. doi: 10.1016/j.jocd.2016.09.005. Epub 2016 Dec 9.
9
Differential modulation of zoledronate and etidronate in osseous healing of an extracted socket and tibia defect.唑来膦酸和依替膦酸对拔牙窝和胫骨缺损骨愈合的差异调节作用
Oral Surg Oral Med Oral Pathol Oral Radiol. 2017 Jan;123(1):8-19. doi: 10.1016/j.oooo.2016.08.009. Epub 2016 Aug 18.
10
Preexisting Periapical Inflammatory Condition Exacerbates Tooth Extraction-induced Bisphosphonate-related Osteonecrosis of the Jaw Lesions in Mice.既往根尖周炎症状态会加重拔牙诱导的小鼠双膦酸盐相关颌骨坏死病变。
J Endod. 2016 Nov;42(11):1641-1646. doi: 10.1016/j.joen.2016.07.020. Epub 2016 Sep 13.